NTLA Intellia Therapeutics | $14.22 -7.9% | 7/10/2026 | | Boost Price Target | $12.00 ➝ $17.00 | Neutral | 00.00% | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 7/10/2026 |
VERA Vera Therapeutics | $42.00 -1.1% | 7/8/2026 | | Boost Price Target | $35.00 ➝ $43.00 | Neutral | 00.00% | View details for Wedbush rating of Vera Therapeutics (NASDAQ:VERA) on 7/8/2026 |
TLX Telix Pharmaceuticals | $11.14 -5.4% | 7/6/2026 | | Reiterated Rating | $22.00 | Outperform | 00.00% | View details for Wedbush rating of Telix Pharmaceuticals (NASDAQ:TLX) on 7/6/2026 |
RVMD Revolution Medicines | $186.88 -2.2% | 7/2/2026 | | Boost Price Target | $165.00 ➝ $181.00 | Outperform | 00.00% | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 7/2/2026 |
CRM Salesforce | $163.34 +0.5% | 7/1/2026 | | Initiated Coverage | | Outperform | 00.00% | View details for Wedbush rating of Salesforce (NYSE:CRM) on 7/1/2026 |
PL Planet Labs PBC | $26.07 -4.2% | 7/1/2026 | | Initiated Coverage | $50.00 | Outperform | 00.00% | View details for Wedbush rating of Planet Labs PBC (NYSE:PL) on 7/1/2026 |
VOYG Voyager Technologies | $31.15 -4.6% | 7/1/2026 | | Initiated Coverage | $60.00 ➝ $46.00 | Outperform | 00.00% | View details for Wedbush rating of Voyager Technologies (NYSE:VOYG) on 7/1/2026 |
ZURA Zura Bio | $5.11 -7.3% | 7/1/2026 | | Reiterated Rating | $15.00 | Outperform | 00.00% | View details for Wedbush rating of Zura Bio (NASDAQ:ZURA) on 7/1/2026 |
SPCX SpaceX | $145.30 -4.5% | 6/30/2026 | | Initiated Coverage | $190.00 | Outperform | 00.00% | View details for Wedbush rating of SpaceX (NASDAQ:SPCX) on 6/30/2026 |
AVAV AeroVironment | $144.58 -2.6% | 6/30/2026 | | Initiated Coverage | $250.00 | Outperform | 00.00% | View details for Wedbush rating of AeroVironment (NASDAQ:AVAV) on 6/30/2026 |
Get the Latest News and Ratings for Your Stocks Enter your email address below to receive the latest headlines and analysts' recommendations for your stocks with our free daily email newsletter.
|
AVAV AeroVironment | $144.58 -2.6% | 6/30/2026 | | Initiated Coverage | $250.00 | Outperform | 00.00% | View details for Wedbush rating of AeroVironment (NASDAQ:AVAV) on 6/30/2026 |
SPCX SpaceX | $145.30 -4.5% | 6/30/2026 | | Initiated Coverage | $190.00 | Outperform | 00.00% | View details for Wedbush rating of SpaceX (NASDAQ:SPCX) on 6/30/2026 |
KTOS Kratos Defense & Security Solutions | $48.19 -1.4% | 6/30/2026 | | Initiated Coverage | $85.00 | Outperform | 00.00% | View details for Wedbush rating of Kratos Defense & Security Solutions (NASDAQ:KTOS) on 6/30/2026 |
ABVX Abivax | $139.90 -0.6% | 6/30/2026 | | Boost Price Target | $90.00 ➝ $110.00 | Neutral | 00.00% | View details for Wedbush rating of Abivax (NASDAQ:ABVX) on 6/30/2026 |
AVAV AeroVironment | $144.58 -2.6% | 6/30/2026 | | Initiated Coverage | $250.00 | Outperform | 00.00% | View details for Wedbush rating of AeroVironment (NASDAQ:AVAV) on 6/30/2026 |
KTOS Kratos Defense & Security Solutions | $48.19 -1.4% | 6/30/2026 | | Initiated Coverage | $85.00 | Outperform | 00.00% | View details for Wedbush rating of Kratos Defense & Security Solutions (NASDAQ:KTOS) on 6/30/2026 |
REPL Replimune Group | $10.99 -1.1% | 6/30/2026 | | Boost Price Target | $6.00 ➝ $9.00 | Neutral | 00.00% | View details for Wedbush rating of Replimune Group (NASDAQ:REPL) on 6/30/2026 |
SPCX SpaceX | $145.30 -4.5% | 6/30/2026 | | Initiated Coverage | $190.00 | Outperform | 00.00% | View details for Wedbush rating of SpaceX (NASDAQ:SPCX) on 6/30/2026 |
VOYG Voyager Technologies | $31.15 -4.6% | 6/30/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Wedbush rating of Voyager Technologies (NYSE:VOYG) on 6/30/2026 |
VRDN Viridian Therapeutics | $19.74 -2.3% | 6/30/2026 | | Boost Price Target | $32.00 ➝ $43.00 | Outperform | 00.00% | View details for Wedbush rating of Viridian Therapeutics (NASDAQ:VRDN) on 6/30/2026 |
KNSA Kiniksa Pharmaceuticals International | $63.44 -3.0% | 6/29/2026 | | Boost Price Target | $59.00 ➝ $72.00 | Outperform | 00.00% | View details for Wedbush rating of Kiniksa Pharmaceuticals International (NASDAQ:KNSA) on 6/29/2026 |
INFQ Infleqtion | $11.18 -4.8% | 6/26/2026 | | Initiated Coverage | $20.00 | Outperform | 00.00% | View details for Wedbush rating of Infleqtion (NYSE:INFQ) on 6/26/2026 |
INFQ Infleqtion | $11.18 -4.8% | 6/26/2026 | | Initiated Coverage | $20.00 | Outperform | 00.00% | View details for Wedbush rating of Infleqtion (NYSE:INFQ) on 6/26/2026 |
MU Micron Technology | $979.30 -1.2% | 6/25/2026 | | Boost Price Target | $1,300.00 ➝ $1,400.00 | Outperform | 00.00% | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 6/25/2026 |
CBRS Cerebras Systems | $215.08 +8.3% | 6/24/2026 | | Boost Price Target | $270.00 ➝ $280.00 | Outperform | 00.00% | View details for Wedbush rating of Cerebras Systems (NASDAQ:CBRS) on 6/24/2026 |
VRNS Varonis Systems | $44.53 -2.8% | 6/24/2026 | | Reiterated Rating | $37.00 | Outperform | 00.00% | View details for Wedbush rating of Varonis Systems (NASDAQ:VRNS) on 6/24/2026 |
BBBY Bed Bath & Beyond | $5.24 -4.6% | 6/23/2026 | | Boost Price Target | $8.00 ➝ $10.00 | Outperform | 00.00% | View details for Wedbush rating of Bed Bath & Beyond (NYSE:BBBY) on 6/23/2026 |
TCRX TScan Therapeutics | $1.09 +2.8% | 6/23/2026 | | Reiterated Rating | $5.00 | Outperform | 00.00% | View details for Wedbush rating of TScan Therapeutics (NASDAQ:TCRX) on 6/23/2026 |
APGE Apogee Therapeutics | $133.65 +0.1% | 6/22/2026 | | Downgrade | $135.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Apogee Therapeutics (NASDAQ:APGE) on 6/22/2026 |
SIMO Silicon Motion Technology | $326.35 +0.6% | 6/22/2026 | | Boost Price Target | $230.00 ➝ $400.00 | Outperform | 00.00% | View details for Wedbush rating of Silicon Motion Technology (NASDAQ:SIMO) on 6/22/2026 |
TVTX Travere Therapeutics | $56.59 -3.2% | 6/22/2026 | | Boost Price Target | $55.00 ➝ $61.00 | Outperform | 00.00% | View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 6/22/2026 |
MU Micron Technology | $979.30 -1.2% | 6/18/2026 | | Boost Price Target | $500.00 ➝ $1,300.00 | Outperform | 00.00% | View details for Wedbush rating of Micron Technology (NASDAQ:MU) on 6/18/2026 |
PLTR Palantir Technologies | $126.79 -1.7% | 6/16/2026 | | Initiated Coverage | | Outperform | 00.00% | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 6/16/2026 |
TRIP TripAdvisor | $13.98 +4.9% | 6/16/2026 | | Boost Price Target | $19.00 ➝ $20.00 | Outperform | 00.00% | View details for Wedbush rating of TripAdvisor (NASDAQ:TRIP) on 6/16/2026 |
SYRE Spyre Therapeutics | $97.74 -1.0% | 6/16/2026 | | Reiterated Rating | $100.00 | Outperform | 00.00% | View details for Wedbush rating of Spyre Therapeutics (NASDAQ:SYRE) on 6/16/2026 |
ROKU Roku | $140.69 +0.3% | 6/16/2026 | | Downgrade | $155.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Roku (NASDAQ:ROKU) on 6/16/2026 |
FLUT Flutter Entertainment | $110.84 +0.0% | 6/15/2026 | | Initiated Coverage | $138.00 | Outperform | 00.00% | View details for Wedbush rating of Flutter Entertainment (NYSE:FLUT) on 6/15/2026 |
DDOG Datadog | $257.54 -4.3% | 6/15/2026 | | Initiated Coverage | | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Datadog (NASDAQ:DDOG) on 6/15/2026 |
EPAM EPAM Systems | $83.89 -3.9% | 6/15/2026 | | Initiated Coverage | $99.00 | Sector Perform ➝ Neutral | 00.00% | View details for Wedbush rating of EPAM Systems (NYSE:EPAM) on 6/15/2026 |
EPAM EPAM Systems | $83.89 -3.9% | 6/15/2026 | | Initiated Coverage | $99.00 | Sector Perform ➝ Neutral | 00.00% | View details for Wedbush rating of EPAM Systems (NYSE:EPAM) on 6/15/2026 |
The REAL Reason Trump is Invading Iran (Ad) For a moment…
Forget about Trump’s ties to Israel.
Forget about reports of Iran’s nuclear program.
Because my research has led me to believe we’re risking World War 3 with Iran for a completely different reason. Click here to find out what it is. |
FLUT Flutter Entertainment | $110.84 +0.0% | 6/15/2026 | | Upgrade | | Strong-Buy | 00.00% | View details for Wedbush rating of Flutter Entertainment (NYSE:FLUT) on 6/15/2026 |
NTLA Intellia Therapeutics | $14.22 -7.9% | 6/15/2026 | | Reiterated Rating | $12.00 | Neutral | 00.00% | View details for Wedbush rating of Intellia Therapeutics (NASDAQ:NTLA) on 6/15/2026 |
CLYM Climb Bio | $14.00 +1.3% | 6/12/2026 | | Reiterated Rating | $17.00 | Outperform | 00.00% | View details for Wedbush rating of Climb Bio (NASDAQ:CLYM) on 6/12/2026 |
DMRA Damora Therapeutics, Inc. Common Stock | $28.53 -7.3% | 6/12/2026 | | Reiterated Rating | $35.00 | Outperform | 00.00% | View details for Wedbush rating of Damora Therapeutics, Inc. Common Stock (NASDAQ:DMRA) on 6/12/2026 |
IDYA IDEAYA Biosciences | $36.99 -0.8% | 6/12/2026 | | Reiterated Rating | $58.00 | Outperform | 00.00% | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 6/12/2026 |
IMNM Immunome | $23.35 -3.4% | 6/12/2026 | | Reiterated Rating | $31.00 | Outperform | 00.00% | View details for Wedbush rating of Immunome (NASDAQ:IMNM) on 6/12/2026 |
ORCL Oracle | $140.69 -2.4% | 6/11/2026 | | Lower Price Target | $275.00 ➝ $240.00 | Outperform | 00.00% | View details for Wedbush rating of Oracle (NYSE:ORCL) on 6/11/2026 |
ORCL Oracle | $140.69 -2.4% | 6/11/2026 | | Lower Price Target | $275.00 ➝ $240.00 | Outperform | 00.00% | View details for Wedbush rating of Oracle (NYSE:ORCL) on 6/11/2026 |
ARGX argenex | $877.62 -3.5% | 6/11/2026 | | Reiterated Rating | $1,000.00 | Outperform | 00.00% | View details for Wedbush rating of argenex (NASDAQ:ARGX) on 6/11/2026 |
CGEM Cullinan Therapeutics | $18.13 -1.4% | 6/11/2026 | | Reiterated Rating | $37.00 | Outperform | 00.00% | View details for Wedbush rating of Cullinan Therapeutics (NASDAQ:CGEM) on 6/11/2026 |
RBRK Rubrik | $84.23 -5.1% | 6/11/2026 | | Reiterated Rating | $90.00 | Outperform | 00.00% | View details for Wedbush rating of Rubrik (NYSE:RBRK) on 6/11/2026 |
DDOG Datadog | $257.54 -4.3% | 6/10/2026 | | Boost Price Target | $220.00 ➝ $260.00 | Outperform | 00.00% | View details for Wedbush rating of Datadog (NASDAQ:DDOG) on 6/10/2026 |
IRON Disc Medicine | $76.59 -3.0% | 6/10/2026 | | Reiterated Rating | $88.00 | Outperform | 00.00% | View details for Wedbush rating of Disc Medicine (NASDAQ:IRON) on 6/10/2026 |
NICE NiCE | $99.74 +1.9% | 6/10/2026 | | Lower Price Target | $120.00 ➝ $100.00 | Neutral | 00.00% | View details for Wedbush rating of NiCE (NASDAQ:NICE) on 6/10/2026 |
RNAC Cartesian Therapeutics | $9.46 -2.2% | 6/10/2026 | | Reiterated Rating | $38.00 | Outperform | 00.00% | View details for Wedbush rating of Cartesian Therapeutics (NASDAQ:RNAC) on 6/10/2026 |
VFS VinFast Auto | $3.05 +0.7% | 6/10/2026 | | Reiterated Rating | $6.00 | Outperform | 00.00% | View details for Wedbush rating of VinFast Auto (NASDAQ:VFS) on 6/10/2026 |
ZS Zscaler | $139.27 -5.3% | 6/10/2026 | | Reiterated Rating | $220.00 | Outperform | 00.00% | View details for Wedbush rating of Zscaler (NASDAQ:ZS) on 6/10/2026 |
NUVL Nuvalent | $123.90 +0.1% | 6/9/2026 | | Downgrade | $125.00 ➝ $124.00 | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Nuvalent (NASDAQ:NUVL) on 6/9/2026 |
CROX Crocs | $132.78 +4.4% | 6/8/2026 | | Initiated Coverage | | Buy ➝ Outperform | 00.00% | View details for Wedbush rating of Crocs (NASDAQ:CROX) on 6/8/2026 |
CBRS Cerebras Systems | $215.08 +8.3% | 6/8/2026 | | Initiated Coverage | $270.00 | Outperform | 00.00% | View details for Wedbush rating of Cerebras Systems (NASDAQ:CBRS) on 6/8/2026 |
CBRS Cerebras Systems | $215.08 +8.3% | 6/8/2026 | | Initiated Coverage | $270.00 | Outperform | 00.00% | View details for Wedbush rating of Cerebras Systems (NASDAQ:CBRS) on 6/8/2026 |
CTSH Cognizant Technology Solutions | $42.57 -1.9% | 6/8/2026 | | Upgrade | $56.00 ➝ $70.00 | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of Cognizant Technology Solutions (NASDAQ:CTSH) on 6/8/2026 |
CBRS Cerebras Systems | $215.08 +8.3% | 6/8/2026 | | Initiated Coverage | $270.00 | Outperform | 00.00% | View details for Wedbush rating of Cerebras Systems (NASDAQ:CBRS) on 6/8/2026 |
AAPL Apple | $315.32 -0.3% | 6/5/2026 | | Reiterated Rating | $400.00 | Outperform | 00.00% | View details for Wedbush rating of Apple (NASDAQ:AAPL) on 6/5/2026 |
DOCU Docusign | $49.18 +0.9% | 6/5/2026 | | Lower Price Target | $60.00 ➝ $58.00 | Neutral | 00.00% | View details for Wedbush rating of Docusign (NASDAQ:DOCU) on 6/5/2026 |
PL Planet Labs PBC | $26.07 -4.2% | 6/5/2026 | | Reiterated Rating | $50.00 | Outperform | 00.00% | View details for Wedbush rating of Planet Labs PBC (NYSE:PL) on 6/5/2026 |
PLTR Palantir Technologies | $126.79 -1.7% | 6/5/2026 | | Reiterated Rating | $230.00 | Outperform | 00.00% | View details for Wedbush rating of Palantir Technologies (NASDAQ:PLTR) on 6/5/2026 |
RBRK Rubrik | $84.23 -5.1% | 6/5/2026 | | Reiterated Rating | $90.00 | Outperform | 00.00% | View details for Wedbush rating of Rubrik (NYSE:RBRK) on 6/5/2026 |
AI C3.ai | $8.96 -0.6% | 6/4/2026 | | Reiterated Rating | $15.00 | Outperform | 00.00% | View details for Wedbush rating of C3.ai (NYSE:AI) on 6/4/2026 |
ARGX argenex | $877.62 -3.5% | 6/4/2026 | | Reiterated Rating | $1,000.00 | Outperform | 00.00% | View details for Wedbush rating of argenex (NASDAQ:ARGX) on 6/4/2026 |
CRWD CrowdStrike | $187.18 -5.7% | 6/4/2026 | | Boost Price Target | $175.00 ➝ $180.00 | Outperform | 00.00% | View details for Wedbush rating of CrowdStrike (NASDAQ:CRWD) on 6/4/2026 |
INOD Innodata | $67.80 -2.0% | 6/4/2026 | | Boost Price Target | $100.00 ➝ $120.00 | Outperform | 00.00% | View details for Wedbush rating of Innodata (NASDAQ:INOD) on 6/4/2026 |
PANW Palo Alto Networks | $325.91 -3.7% | 6/3/2026 | | Boost Price Target | $300.00 ➝ $340.00 | Outperform | 00.00% | View details for Wedbush rating of Palo Alto Networks (NASDAQ:PANW) on 6/3/2026 |
RZLT Rezolute | $4.75 -7.4% | 6/3/2026 | | Boost Price Target | $5.00 ➝ $6.00 | Outperform | 00.00% | View details for Wedbush rating of Rezolute (NASDAQ:RZLT) on 6/3/2026 |
TVTX Travere Therapeutics | $56.59 -3.2% | 6/3/2026 | | Reiterated Rating | $55.00 | Outperform | 00.00% | View details for Wedbush rating of Travere Therapeutics (NASDAQ:TVTX) on 6/3/2026 |
META Meta Platforms | $669.21 +6.0% | 6/2/2026 | | Upgrade | | Outperform ➝ Neutral | 00.00% | View details for Wedbush rating of Meta Platforms (NASDAQ:META) on 6/2/2026 |
IBM International Business Machines | $287.85 -2.5% | 6/2/2026 | | Set Price Target | $350.00 | | 00.00% | View details for Wedbush rating of International Business Machines (NYSE:IBM) on 6/2/2026 |
TRIP TripAdvisor | $13.98 +4.9% | 6/2/2026 | | Initiated Coverage | $19.00 | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of TripAdvisor (NASDAQ:TRIP) on 6/2/2026 |
ABVX Abivax | $139.90 -0.6% | 6/2/2026 | | Upgrade | $110.00 ➝ $90.00 | Underperform ➝ Neutral | 00.00% | View details for Wedbush rating of Abivax (NASDAQ:ABVX) on 6/2/2026 |
IDYA IDEAYA Biosciences | $36.99 -0.8% | 6/2/2026 | | Reiterated Rating | $58.00 | Outperform | 00.00% | View details for Wedbush rating of IDEAYA Biosciences (NASDAQ:IDYA) on 6/2/2026 |
JBIO Jade Biosciences | $20.95 -6.8% | 6/2/2026 | | Boost Price Target | $34.00 ➝ $45.00 | Outperform | 00.00% | View details for Wedbush rating of Jade Biosciences (NASDAQ:JBIO) on 6/2/2026 |
ODTX Odyssey Therapeutics | $16.69 -0.8% | 6/2/2026 | | Initiated Coverage | $30.00 | Outperform | 00.00% | View details for Wedbush rating of Odyssey Therapeutics (NASDAQ:ODTX) on 6/2/2026 |
PRAX Praxis Precision Medicines | $324.99 -2.4% | 6/2/2026 | | Lower Price Target | $166.00 ➝ $162.00 | Underperform | 00.00% | View details for Wedbush rating of Praxis Precision Medicines (NASDAQ:PRAX) on 6/2/2026 |
TRIP TripAdvisor | $13.98 +4.9% | 6/2/2026 | | Initiated Coverage | $19.00 | Neutral ➝ Outperform | 00.00% | View details for Wedbush rating of TripAdvisor (NASDAQ:TRIP) on 6/2/2026 |
EWTX Edgewise Therapeutics | $45.41 -6.1% | 6/1/2026 | | Boost Price Target | $46.00 ➝ $52.00 | Outperform | 00.00% | View details for Wedbush rating of Edgewise Therapeutics (NASDAQ:EWTX) on 6/1/2026 |
RVMD Revolution Medicines | $186.88 -2.2% | 6/1/2026 | | Reiterated Rating | | Outperform | 00.00% | View details for Wedbush rating of Revolution Medicines (NASDAQ:RVMD) on 6/1/2026 |
REPL Replimune Group | $10.99 -1.1% | 6/1/2026 | | Boost Price Target | $2.00 ➝ $6.00 | Neutral | 00.00% | View details for Wedbush rating of Replimune Group (NASDAQ:REPL) on 6/1/2026 |
DY Dycom Industries | $425.25 -0.5% | 5/29/2026 | | Set Price Target | $654.00 | | 00.00% | View details for Wedbush rating of Dycom Industries (NYSE:DY) on 5/29/2026 |
VOYG Voyager Technologies | $31.15 -4.6% | 5/29/2026 | | Boost Price Target | $46.00 ➝ $60.00 | Outperform | 00.00% | View details for Wedbush rating of Voyager Technologies (NYSE:VOYG) on 5/29/2026 |
OKTA Okta | $138.63 -6.9% | 5/29/2026 | | Reiterated Rating | $60.00 | Outperform | 00.00% | View details for Wedbush rating of Okta (NASDAQ:OKTA) on 5/29/2026 |
Trump's New Dollar (Ad) Porter Stansberry says President Trump has signed an executive order initiating what he calls a full U.S. dollar reset - and most Americans don't know it's happening.
The last time America underwent a monetary shift like this, under Nixon in the 1970s, it minted an average of 1,300 new millionaires a day for over half a century. Stansberry has released a new documentary naming the assets he believes are positioned to surge as a result. Watch the free briefing and see the three steps to prepare today |
BBY Best Buy | $82.97 +3.7% | 5/29/2026 | | Boost Price Target | $70.00 ➝ $75.00 | Neutral | 00.00% | View details for Wedbush rating of Best Buy (NYSE:BBY) on 5/29/2026 |
COGT Cogent Biosciences | $38.87 -4.0% | 5/29/2026 | | Reiterated Rating | $55.00 | Outperform | 00.00% | View details for Wedbush rating of Cogent Biosciences (NASDAQ:COGT) on 5/29/2026 |
ESTC Elastic | $60.31 -2.8% | 5/29/2026 | | Lower Price Target | $74.00 ➝ $65.00 | Outperform | 00.00% | View details for Wedbush rating of Elastic (NYSE:ESTC) on 5/29/2026 |
IBM International Business Machines | $287.85 -2.5% | 5/29/2026 | | Reiterated Rating | $320.00 | Outperform | 00.00% | View details for Wedbush rating of International Business Machines (NYSE:IBM) on 5/29/2026 |
MDB MongoDB | $342.08 -5.7% | 5/29/2026 | | Boost Price Target | $380.00 ➝ $390.00 | Outperform | 00.00% | View details for Wedbush rating of MongoDB (NASDAQ:MDB) on 5/29/2026 |
NTAP NetApp | $168.87 -1.7% | 5/29/2026 | | Boost Price Target | $115.00 ➝ $150.00 | Neutral | 00.00% | View details for Wedbush rating of NetApp (NASDAQ:NTAP) on 5/29/2026 |
S SentinelOne | $17.87 -5.3% | 5/29/2026 | | Reiterated Rating | $20.00 | Outperform | 00.00% | View details for Wedbush rating of SentinelOne (NYSE:S) on 5/29/2026 |
STAA STAAR Surgical | $27.76 -0.8% | 5/29/2026 | | Reiterated Rating | $40.00 | Outperform | 00.00% | View details for Wedbush rating of STAAR Surgical (NASDAQ:STAA) on 5/29/2026 |
P Everpure | $79.27 -2.1% | 5/28/2026 | | Boost Price Target | $100.00 ➝ $105.00 | Outperform | 00.00% | View details for Wedbush rating of Everpure (NYSE:P) on 5/28/2026 |
SNOW Snowflake | $261.57 -2.2% | 5/28/2026 | | Boost Price Target | $270.00 ➝ $280.00 | Outperform | 00.00% | View details for Wedbush rating of Snowflake (NYSE:SNOW) on 5/28/2026 |